Results 31 to 40 of about 100,338 (194)
Oxidative stress in pre-eclampsia; have we been looking in the wrong place? [PDF]
, 2017 Pre-eclampsia is a disorder of late pregnancy. It is a major cause of maternal and perinatal morbidity and mortality, accounting for nearly 18% of all maternal deaths worldwide; an estimated 77,000 maternal deaths per year [1].
Kenny, Louise C. +3 more
core +1 more source
FAS gene polymorphisms (rs3740286 and rs4064) were not associated with pre-eclampsia risk [PDF]
Anais da Academia Brasileira de Ciências, 2020 Pre-eclampsia results in real risk and significant impact on indicators related to maternal and child health. The only known treatment is delivery of the fetus and placenta. Despite intensive research, the causes of PE remain to be elucidated.
SARAH C.S.V. TANAKA +6 more
doaj +1 more source
Cardiac Angiogenic Imbalance Leads to Peripartum Cardiomyopathy [PDF]
, 2013 Peripartum cardiomyopathy (PPCM) is an often fatal disease that affects pregnant women who are near delivery, and it occurs more frequently in women with pre-eclampsia and/or multiple gestation.
Arany, Zoltan Pierre +20 more
core +1 more source
RISK FACTORS AND LABOUR OUTCOME IN PAROUS WOMEN WITH PRE - ECLAMPSIA [PDF]
The Medical Journal of Basrah University, 2006 This is a case-control study, carried out to estimate the frequency of parous women with pre-eclampsia among all deliveries conducted in the study period (September 2004 -September 2005); to identify demographic, medical and obstetrical risk factors that
Methal A. Alrubaee
doaj +1 more source
Low-dose calcium supplementation for preventing pre-eclampsia: a systematic review and commentary. [PDF]
, 2014 BACKGROUND: Epidemiological data link low dietary calcium with pre-eclampsia. Current recommendations are for 1.5-2 g/day calcium supplementation for low-intake pregnant women, based on randomised controlled trials of ≥1 g/day calcium supplementation ...
Belizán, JM +3 more
core +1 more source
BMJ Paediatrics Open, 2022 Background In Ethiopia, in 2021, more than 80% of all newborn deaths were caused by preventable and treatable conditions. This study aimed to measure the incidence of adverse perinatal outcomes and risk factors among women with pre-eclampsia in the ...
Kassahun Alemu Gelaye +3 more
doaj +1 more source
Pre-eclampsia, Soluble fms-like Tyrosine Kinase 1, and the Risk of Reduced Thyroid Function: Nested Case-Control and Population Based Study [PDF]
, 2013 Objective: To determine if pre-eclampsia is associated with reduced thyroid function during and after pregnancy. Design: Nested case-control study during pregnancy and population based follow-up study after pregnancy.
Asvold, Bjorn O +9 more
core +1 more source
BMC ProceedingsThe 5th Preeclampsia Scientific Symposium (PSS2023) organized by Action on Preeclampsia (APEC) Ghana was themed: ‘Realign, Refocus: Improving outcomes of Hypertensive Disorders of Pregnancy through Shared Decision Making, Research & Quality of Care’.
Koiwah Koi-Larbi +6 more
doaj +1 more source
, 2013 A 33 year old primagravida rhesus positive woman was referred to the Emergency Department by her family doctor at 27 weeks gestation. At 25 weeks of gestation, she had been diagnosed with hypertension and was started on labetalol therapy.
Bugeja, Roberta, Galdes, Caroline
core
Jurnal Biometrika dan Kependudukan, 2019 Pre-eclampsia is the third highest cause of death in pregnant women. Symptoms of pre-eclampsia can be identified by the presence of hypertension, proteinuria and edema during pregnancy until postpartum.
Intan Laraswati, Diah Indriani
doaj +1 more source